[1]
“PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE CLINICAL AND LABORATORY MARKERS”, JournalNX, vol. 8, no. 03, pp. 36–44, Mar. 2022, doi: 10.17605/OSF.IO/VQT6N.